{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:11:59Z","timestamp":1792649519707,"version":"4.5.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167935","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T20:38:53Z","timestamp":1483994333000},"page":"e0167935","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties"],"prefix":"10.1371","volume":"11","author":[{"given":"Andrew C.","family":"Nyborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoy","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luba","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Geoghegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Wendeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bartnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviu","family":"Gruia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidyashankara","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varnika","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clynn","family":"Wilker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Jermutus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herren","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Osbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Baca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"issue":"Pt 8","key":"ref1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1107\/S0907444908013590","article-title":"Structures of Arthrobacter globiformis urate oxidase-ligand complexes","volume":"D64","author":"EC Juan","year":"2008","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nchembio768","article-title":"Completing the uric acid degradation pathway through phylogenetic comparison of whole genomes","volume":"2","author":"I Ramazzina","year":"2006","journal-title":"Nature chemical biology"},{"issue":"33","key":"ref3","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1021\/bi980446g","article-title":"Spectroscopic characterization of intermediates in the urate oxidase reaction","volume":"37","author":"K Kahn","year":"1998","journal-title":"Biochemistry"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1073\/pnas.1320393111","article-title":"Evolutionary history and metabolic insights of ancient mammalian uricases","volume":"111","author":"JT Kratzer","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"15","key":"ref5","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1096\/fasebj.2.15.3192041","article-title":"Uricase protein sequences: conserved during vertebrate evolution but absent in humans","volume":"2","author":"A Varela-Echavarria","year":"1988","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/rheumatology\/keq204","article-title":"Uric acid and evolution","volume":"49","author":"B Alvarez-Lario","year":"2010","journal-title":"Rheumatology"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semnephrol.2004.09.002","article-title":"Uric acid, evolution and primitive cultures","volume":"25","author":"RJ Johnson","year":"2005","journal-title":"Seminars in nephrology"},{"issue":"32","key":"ref8","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"GK Glantzounis","year":"2005","journal-title":"Current pharmaceutical design"},{"issue":"4459","key":"ref9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/175683a0","article-title":"The origin of man","volume":"175","author":"E Orowan","year":"1955","journal-title":"Nature"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jmg.18.6.410","article-title":"Genes for super-intelligence?","volume":"18","author":"JA Sofaer","year":"1981","journal-title":"Journal of medical genetics"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000028589.66335.AA","article-title":"Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity","volume":"40","author":"S Watanabe","year":"2002","journal-title":"Hypertension"},{"issue":"5","key":"ref12","first-page":"539","article-title":"Uric acid and cardiovascular risk","volume":"360","author":"MS Parmar","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"48","key":"ref13","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver","volume":"287","author":"MA Lanaspa","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"9711","key":"ref14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"P Richette","year":"2010","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.curtheres.2013.04.003","article-title":"A revised estimate of the burden of illness of gout","volume":"75","author":"A Wertheimer","year":"2013","journal-title":"Current therapeutic research, clinical and experimental"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/art.1780090306","article-title":"Effects of allopurinol, a xanthine oxidase inhibitor, and sulfinpyrazone upon the urinary and serum urate concentrations in eight patients with tophaceous gout","volume":"9","author":"E Goldfarb","year":"1966","journal-title":"Arthritis and rheumatism"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"IA Bobulescu","year":"2012","journal-title":"Advances in chronic kidney disease"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/BOR.0000000000000035","article-title":"Uricosuric drugs: the once and future therapy for hyperuricemia?","volume":"26","author":"MH Bach","year":"2014","journal-title":"Current opinion in rheumatology"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials","volume":"306","author":"JS Sundy","year":"2011","journal-title":"Jama"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1200\/JCO.2003.04.115","article-title":"Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study","volume":"21","author":"B Coiffier","year":"2003","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"32","key":"ref21","doi-asserted-by":"crossref","first-page":"14351","DOI":"10.1073\/pnas.1001072107","article-title":"Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo","volume":"107","author":"MS Hershfield","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1861","article-title":"Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase","volume":"8","author":"NJ Ganson","year":"2006","journal-title":"Arthritis research & therapy"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.22403","article-title":"Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout","volume":"56","author":"JS Sundy","year":"2007","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/RHU.0000000000000200","article-title":"Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy","volume":"20","author":"HS Baraf","year":"2014","journal-title":"Journal of clinical rheumatology: practical reports on rheumatic & musculoskeletal diseases"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar4497","article-title":"Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout","volume":"16","author":"PE Lipsky","year":"2014","journal-title":"Arthritis research & therapy"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000351048","article-title":"Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency","volume":"130","author":"CY Cheah","year":"2013","journal-title":"Acta haematologica"},{"issue":"Pt 1","key":"ref27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BA20010083","article-title":"Modification of a reactive cysteine explains differences between rasburicase and Uricozyme, a natural Aspergillus flavus uricase","volume":"36","author":"A Bayol","year":"2002","journal-title":"Biotechnology and applied biochemistry"},{"issue":"3","key":"ref28","first-page":"275","article-title":"Rasburicase (Elitek): a novel agent for tumor lysis syndrome","volume":"18","author":"S Ueng","year":"2005","journal-title":"Proceedings"},{"issue":"2","key":"ref29","first-page":"125","article-title":"Functional expression and peroxisomal targeting of rat urate oxidase in monkey kidney cells","volume":"5","author":"AV Yeldandi","year":"1995","journal-title":"Gene expression"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1432-1033.1969.tb00626.x","article-title":"Urate oxidase and its association with peroxisomes in Acanthamoeba sp","volume":"9","author":"M Muller","year":"1969","journal-title":"European journal of biochemistry \/ FEBS"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0301-4622(94)00150-I","article-title":"Study of pH and temperature-induced transitions in urate oxidase (Uox-EC1.7.3.3) by microcalorimetry (DSC), size exclusion chromatography (SEC) and enzymatic activity experiments","volume":"54","author":"A Bayol","year":"1995","journal-title":"Biophysical chemistry"},{"issue":"9","key":"ref32","first-page":"1942","article-title":"Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies","volume":"29","author":"JS Bomalaski","year":"2002","journal-title":"The Journal of rheumatology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev.cellbio.12.1.697","article-title":"RGD and other recognition sequences for integrins","volume":"12","author":"E Ruoslahti","year":"1996","journal-title":"Annual review of cell and developmental biology"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd3266","article-title":"Integrins as therapeutic targets: lessons and opportunities","volume":"9","author":"D Cox","year":"2010","journal-title":"Nature reviews Drug discovery"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.113.4.919","article-title":"Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface","volume":"113","author":"EA Wayner","year":"1991","journal-title":"The Journal of cell biology"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1002\/jps.21278","article-title":"The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics","volume":"97","author":"CS Fishburn","year":"2008","journal-title":"Journal of pharmaceutical sciences"},{"issue":"1\u20132","key":"ref37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2012.03.057","article-title":"Characterization, efficacy, pharmacokinetics, and biodistribution of 5kDa mPEG modified tetrameric canine uricase variant","volume":"430","author":"C Zhang","year":"2012","journal-title":"International journal of pharmaceutics"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/clinchem\/33.8.1427","article-title":"Deproteinizing methods evaluated for determination of uric acid in serum by reversed-phase liquid chromatography with ultraviolet detection","volume":"33","author":"R Sakuma","year":"1987","journal-title":"Clinical chemistry"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1373\/clinchem.2006.081414","article-title":"Perchloric acid treatment to stabilize uric acid concentrations in blood samples of patients receiving uric acid oxidase (rasburicase) therapy","volume":"53","author":"V Stove","year":"2007","journal-title":"Clinical chemistry"},{"key":"ref40","unstructured":"Hershfield MS, Kelly SJ, inventors; Duke University, assignee. Urate Oxidase. USA patent US 7056713 B1. 2006."},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s11095-013-1067-7","article-title":"The immunogenicity of polyethylene glycol: facts and fiction","volume":"30","author":"H Schellekens","year":"2013","journal-title":"Pharmaceutical research"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"RP Garay","year":"2012","journal-title":"Expert opinion on drug delivery"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"e39659","DOI":"10.1371\/journal.pone.0039659","article-title":"Impact of large aggregated uricases and PEG diol on accelerated blood clearance of PEGylated canine uricase","volume":"7","author":"C Zhang","year":"2012","journal-title":"PloS one"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clim.2013.09.006","article-title":"T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation","volume":"149","author":"V Jawa","year":"2013","journal-title":"Clinical immunology"},{"key":"ref45","first-page":"351","article-title":"Current trends in monoclonal antibody development and manufacturing","volume":"xiv","author":"SJ Shire","year":"2010"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0971-4065.139092","article-title":"Single dose rasburicase in the management of tumor lysis syndrome in childhood acute lymphoblastic leukemia: A case series","volume":"25","author":"SM Latha","year":"2015","journal-title":"Indian journal of nephrology"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-2697(89)90602-7","article-title":"Calculation of protein extinction coefficients from amino acid sequence data","volume":"182","author":"SC Gill","year":"1989","journal-title":"Analytical biochemistry"},{"issue":"2","key":"ref48","first-page":"625","article-title":"Studies on uricase. I. Preparation, purification, and properties of a cuproprotein","volume":"216","author":"HR Mahler","year":"1955","journal-title":"The Journal of biological chemistry"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0003-2697(02)00293-2","article-title":"A colorimetric 96-well microtiter plate assay for the determination of urate oxidase activity and its kinetic parameters","volume":"309","author":"L Fraisse","year":"2002","journal-title":"Analytical biochemistry"},{"issue":"21","key":"ref50","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1073\/pnas.90.21.10003","article-title":"High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site","volume":"90","author":"CF Barbas 3rd","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T19:24:43Z","timestamp":1601321083000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167935"}},"subtitle":[],"editor":[{"given":"Marco","family":"Rito-Palomares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,21]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167935","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,21]]}}}